Captrust Financial Advisors »

Vir Biotechnology shares owned by Captrust Financial Advisors

Quarter-by-quarter ownership of Vir Biotechnology (VIR) shares owned by Captrust Financial Advisors from 13F filings

Historical chart of Captrust Financial Advisors investment in Vir Biotechnology

Tip: Access up to 7 years of quarterly data

All positions including Vir Biotechnology held by Captrust Financial Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vir Biotechnology by Captrust Financial Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $109k 19k 5.71
2025-06-30 $155k 31k 5.04
2025-03-31 $143k 22k 6.48
2024-12-31 $151k 21k 7.34
2024-09-30 $119k 16k 7.49
2022-06-30 $46k 1.8k 25.23
2022-03-31 $3.0k 133 22.56
2021-12-31 $6.0k 136 44.12
2020-12-31 $13k 500 26.00

More positions owned by Captrust Financial Advisors

Ishares Core S&p 500 Etf Etf (IVV)
Vanguard Ftse Developed Markets Etf Etf (VEA)
Apple Stock (AAPL)
Ishares 1-3 Year Treasury Bond Etf Etf (SHY)
Microsoft Corp Stock (MSFT)
Vanguard Value Etf (VTV)
Nvidia Corporation Stock (NVDA)
Vanguard S&p 500 Etf Etf (VOO)
Vanguard Growth Etf Etf (VUG)
Ishares Core Msci Total International Stock Etf Etf (IXUS)
Ishares 3-7 Year Treasury Bond Etf Etf (IEI)
Vanguard Mega Cap Growth Etf Etf (MGK)
Vanguard Small-cap Etf Etf (VB)
Alphabet Inc Cap Stk Cl A Stock (GOOGL)
Ishares Core Msci Emerging Market Etf Etf (IEMG)

View all positions for Captrust Financial Advisors

Top funds holding Vir Biotechnology

Sb Investment Advisers
BlackRock
Arch Venture Corp
Vanguard Group
State Street Corporation
FMR
Dimensional Fund Advisors
OrbiMed Advisors
Geode Capital Management
Morgan Stanley
Standard Life Aberdeen
Goldman Sachs Group
Millennium Management
Renaissance Technologies
Charles Schwab Investment Management

View all funds holding Vir Biotechnology